Literature DB >> 3029380

Probing the structural domains and function in vivo of Escherichia coli DNA topoisomerase I by mutagenesis.

L Zumstein, J C Wang.   

Abstract

Insertion and deletion mutagenesis within the gene topA of Escherichia coli encoding DNA topoisomerase I was carried out to test the existence of subdomains in the enzyme and the relationship between the slow-growth topA- phenotype and the known DNA relaxation activity of the enzyme. All mutants that show no detectable DNA relaxation activity in cell extracts fail to complement the temperature-sensitive growth defect of strain AS17 topAam harboring a plasmid-borne temperature-sensitive suppressor tRNA. All mutants that show partial or full levels of DNA relaxation activity in cell extracts (relative to activity in extracts of wild-type cells) can complement this defect. The carboxyl-proximal 25% of the enzyme appears to be in a domain that is dispensable both in terms of the catalytic function of the enzyme and its biological role. Analysis of the mutant enzyme also indicates that the formation of the covalent topoisomerase-DNA complex is correlated with the DNA relaxation activity, which supports the notion that the covalent complex is an obligatory intermediate in the catalysis of DNA topoisomerization.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3029380     DOI: 10.1016/0022-2836(86)90130-0

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  24 in total

1.  Conditional growth of Escherichia coli caused by expression of vaccinia virus DNA topoisomerase I.

Authors:  M E Fernandez-Beros; Y C Tse-Dinh
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

2.  Expression of yeast DNA topoisomerase I can complement a conditional-lethal DNA topoisomerase I mutation in Escherichia coli.

Authors:  M A Bjornsti; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Establishment of unipolar localization of IcsA in Shigella flexneri 2a is not dependent on virulence plasmid determinants.

Authors:  R C Sandlin; A T Maurelli
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Escherichia coli DNA topoisomerase I and suppression of killing by Tn5 transposase overproduction: topoisomerase I modulates Tn5 transposition.

Authors:  H Yigit; W S Reznikoff
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

5.  Human TOP3: a single-copy gene encoding DNA topoisomerase III.

Authors:  R Hanai; P R Caron; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 6.  Type IA topoisomerases can be "magicians" for both DNA and RNA in all domains of life.

Authors:  Muzammil Ahmad; Dongyi Xu; Weidong Wang
Journal:  RNA Biol       Date:  2017-05-23       Impact factor: 4.652

7.  The DNA relaxation activity and covalent complex accumulation of Mycobacterium tuberculosis topoisomerase I can be assayed in Escherichia coli: application for identification of potential FRET-dye labeling sites.

Authors:  Gagandeep Narula; Jennifer Becker; Bokun Cheng; Neil Dani; Maria V Abrenica; Yuk-Ching Tse-Dinh
Journal:  BMC Biochem       Date:  2010-09-30       Impact factor: 4.059

8.  Functional analysis of the ffh-trmD region of the Escherichia coli chromosome by using reverse genetics.

Authors:  B C Persson; G O Bylund; D E Berg; P M Wikström
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

9.  Iron inhibits Escherichia coli topoisomerase I activity by targeting the first two zinc-binding sites in the C-terminal domain.

Authors:  Wu Wang; Xiaolu Su; Xiaobing Wang; Juanjuan Yang; Ting Zhang; Maofeng Wang; Rugen Wan; Guoqiang Tan; Jianxin Lu
Journal:  Protein Sci       Date:  2014-09-13       Impact factor: 6.725

10.  Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase I from a new expression and purification protocol.

Authors:  Thirunavukkarasu Annamalai; Neil Dani; Bokun Cheng; Yuk-Ching Tse-Dinh
Journal:  BMC Biochem       Date:  2009-06-11       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.